Abstract:Plants and microbes commonly make terpenes and terpenoids in small amounts and as complex mixtures, and their chemical synthesis is often costly and inefficient. Hence, there are many efforts to create robust and efficient biological production platforms for this interesting class of molecules. In this study, our effort was directed towards building a yeast production platform using an unbiased genetic selection approach. Yeast strain BY4741 was subjected to EMS mutagenesis, followed by selection for growth in the presence of nystatin, squalestatin, and exogenous cholesterol. This unbiased screen selected for mutant yeast lines having a dispensable mevalonate pathway and containing uncharacterized SUE (sterol uptake enhancement) mutations supporting aerobic uptake of exogenous sterol. These mutants were next screened for high level accumulation of farnesol (FOH), an indicator for high level accumulation of the key intermediate FPP, farnesyl diphosphate. To further improve the FPP pool in these mutants, insertional mutations into the ERG9 gene (coding for squalene synthase) were introduced into those lines capable of accumulating ≥50 mg farnesol/L. This generated another series of lines that accumulated farnesol levels over 70 mg/L in small-scale shake cultures. To evaluate the utility of these lines as a general production platform for specific terpenes, select SUE/erg9 lines were transformed with a vector harboring the Hyoscyamus muticus premnaspirodiene synthase (HPS) gene encoding for a sesquiterpene synthase. The new yeast line ZX178-08 accumulated the highest level of premnaspirodiene, up to 116 mg/L, with FOH levels of 23.6 mg/L. In comparison, the parental line BY4741 accumulated 10 times less premnaspirodiene, 10.94 mg/L, with no farnesol detectable. Co-expression of the HPS gene with an amino-terminal truncated, catalytic form of the hamster HMGR gene, tHMGR, increased premnaspirodiene accumulation to 170.23 ± 30.44 mg/L, almost a 50% increase. Further utility of this yeast line was demonstrated for triterpene production. When engineered for the production of a non-native triterpene, Zx178-08 accumulated upwards of 60 mg/L of botryococcene. To engineer more native triterpene accumulation, additional insertion mutants into the ERG1 gene (coding for squalene epoxidase) were evaluated. Insertion of a simple selection marker followed by over-expression of a heterologous squalene synthase gene resulted in greater than 85 mg/L of squalene. However, when the ERG1 insertional mutant included chromosomal insertion of a truncated, heterologous HMGR gene, squalene production was more than tripled to 270 mg/L. These results are discussed in comparison to other recently developed terpene production platforms.

Efficient production of (S)-limonene and geraniol in Saccharomyces cerevisiae through the utilization of an Erg20 mutant with enhanced GPP accumulation capability

Engineering Saccharomyces Cerevisiae YPH499 for Overproduction of Geranylgeraniol.

Progress in Recombinant Construction of Saccharomyces cerevisiae for Improving Ethanol Production

Switching Carbon Metabolic Flux for Enhancing the Production of Sesquiterpene-Based High-Density Biofuel Precursor in Saccharomyces Cerevisiae

Improving monoterpene geraniol production through geranyl diphosphate synthesis regulation in Saccharomyces cerevisiae

Construction of a Highly Efficient Synthetic Lycopene Engineered Saccharomyces Cerevisiae

[Production of limonene and its derivative in Saccharomyces cerevisiae via metabolic engineering]

Improved Linalool Production in Saccharomyces Cerevisiae by Combining Directed Evolution of Linalool Synthase and Overexpression of the Complete Mevalonate Pathway

Combinatorial engineering of Saccharomyces cerevisiae for improving limonene production

Alleviation of the Byproducts Formation Enables Highly Efficient Biosynthesis of Rosmarinic Acid in Saccharomyces cerevisiae

Identification of the sesquiterpene synthase AcTPS1 and high production of (-)-germacrene D in metabolically engineered Saccharomyces cerevisiae

Construction of Lycopene-Overproducing Saccharomyces Cerevisiae by Combining Directed Evolution and Metabolic Engineering.

Combinatorial Modulation of Linalool Synthase and Farnesyl Diphosphate Synthase for Linalool Overproduction in <i>Saccharomyces cerevisiae</i>

High-level Production of Linalool by Engineered Saccharomyces Cerevisiae Harboring Dual Mevalonate Pathways in Mitochondria and Cytoplasm.

Advances in Metabolic Engineering of Saccharomyces Cerevisiae for Terpenoids Biosynthesis

Collaborative subcellular compartmentalization to improve GPP utilization and boost sabinene accumulation in Saccharomyces cerevisiae

A “push-pull-restrain” strategy to improve citronellol production in Saccharomyces cerevisiae

Engineering Saccharomyces cerevisiae for production of the valuable monoterpene d-limonene during Chinese Baijiu fermentation

Building terpene production platforms in yeast

Improvement of Ethanol Production in Saccharomyces Cerevisiae by Hetero-Expression of Gapn and Fps1 Deletion

Capturing of the monoterpene olefin limonene produced in Saccharomyces cerevisiae